share_log

Assure | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

SEC announcement ·  May 17 05:28
Summary by Futu AI
Assure Holdings Corp., a company listed in the United States, has notified the SEC of a delay in filing its quarterly report on Form 10-Q for the period ended March 31, 2024. The delay is due to technical accounting issues related to the disposition of assets to National Neuromonitoring Services, LLC, which was completed on March 26, 2024. Assure requires additional time to finalize its financial statements for inclusion in the Form 10-Q. The company anticipates filing the report by May 20, 2024, which is within the five-day extension period allowed under Rule 12b-25. Assure has confirmed that all other periodic reports have been filed as required. The company also expects to report a significant change in its financial results, with anticipated revenue of approximately $10,000 for...Show More
Assure Holdings Corp., a company listed in the United States, has notified the SEC of a delay in filing its quarterly report on Form 10-Q for the period ended March 31, 2024. The delay is due to technical accounting issues related to the disposition of assets to National Neuromonitoring Services, LLC, which was completed on March 26, 2024. Assure requires additional time to finalize its financial statements for inclusion in the Form 10-Q. The company anticipates filing the report by May 20, 2024, which is within the five-day extension period allowed under Rule 12b-25. Assure has confirmed that all other periodic reports have been filed as required. The company also expects to report a significant change in its financial results, with anticipated revenue of approximately $10,000 for the quarter, down from $3.6 million in the same period the previous year. The expected net loss for the quarter is approximately $3.1 million, an improvement from the $4.3 million net loss reported for the quarter ended March 31, 2023. These changes are primarily due to the reclassification of revenue from clinical operations to discontinued operations and the sale of these clinical operations.

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.